Evidence map›Paper›PMID 36230937›Full record

ArticleCells2022

Retinal Pigment Epithelium-Secreted VEGF-A Induces Alpha-2-Macroglobulin Expression in Endothelial Cells.

Guillermo L Lehmann, Michael Ginsberg, Daniel J Nolan, Cristina Rodríguez, José Martínez-González, Shemin Zeng, Andrew P Voigt, Robert F Mullins, Shahin Rafii, Enrique Rodriguez-Boulan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Targeting Arterial Dysfunction in Cardiovascular Disease Using Stem Cell-Based Therapies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Stromal-Like Cells and Retinal Pigment Epithelium Modulate Choroidal Sprouting Through Galectin-1-Dependent and Independent Pathways.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Guillermo L LehmannMargaret Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medicine, New York, NY 10065, USA.
Michael GinsbergAngiocrine Bioscience, Inc., San Diego, CA 92121, USA.
Daniel J NolanAngiocrine Bioscience, Inc., San Diego, CA 92121, USA.ORCID 0000-0002-4913-0813
Cristina RodríguezInstitut de Recerca Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0002-6472-5647
José Martínez-GonzálezInstitut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), 08041 Barcelona, Spain.ORCID 0000-0002-3894-7166
Shemin ZengInstitute for Vision Research, Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA 52246, USA.
Andrew P VoigtInstitute for Vision Research, Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA 52246, USA.
Robert F MullinsInstitute for Vision Research, Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA 52246, USA.ORCID 0000-0002-5006-0891
Shahin RafiiAnsary Stem Cell Institute, Department of Medicine, Division of Regenerative Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Enrique Rodriguez-BoulanMargaret Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medicine, New York, NY 10065, USA.
Ignacio BenedictoMargaret Dyson Vision Research Institute, Department of Ophthalmology, Weill Cornell Medicine, New York, NY 10065, USA.
University of Iowa · USAngiocrine Bioscience (United States) · USCornell University · USConsejo Superior de Investigaciones Científicas · ESInstituto de Salud Carlos III · ESRegeneron (United States) · USUniversidad Complutense de Madrid · ES

Funding

RETINA--REVERSED POLARITY IN RPER01EY008538 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI RODRIGUEZ-BOULAN, ENRIQUE J · 1991 to 2020
$13.4M
SORTING OF PLASMA MEMBRANE PROTEINS IN EPITHELIAL CELLSR01GM034107 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI RODRIGUEZ-BOULAN, ENRIQUE J · 1985 to 2019
$9.6M
Medical Scientist Training ProgramT32GM139776 · NIGMS · UNIVERSITY OF IOWA · PI Gordon F Buchanan · 2021 to 2026
$6.4M
Choriocapillaris Protection and Replacement in AMDR01EY024605 · NEI · UNIVERSITY OF IOWA · PI Robert Foster Mullins, Budd A Tucker · 2014 to 2026
$4.6M
NEI NIH HHS R01 EY008538NEI NIH HHS R01 EY024605NIGMS NIH HHS R01 GM034107NIGMS NIH HHS T32 GM139776
6 · The paper itself

Abstract

Alpha-2-macroglobulin (A2M) is a protease inhibitor that regulates extracellular matrix (ECM) stability and turnover. Here, we show that A2M is expressed by endothelial cells (ECs) from human eye choroid. We demonstrate that retinal pigment epithelium (RPE)-conditioned medium induces A2M expression specifically in ECs. Experiments using chemical inhibitors, blocking antibodies, and recombinant proteins revealed a key role of VEGF-A in RPE-mediated A2M induction in ECs. Furthermore, incubation of ECs with RPE-conditioned medium reduces matrix metalloproteinase-2 gelatinase activity of culture supernatants, which is partially restored after A2M knockdown in ECs. We propose that dysfunctional RPE or choroidal blood vessels, as observed in retinal diseases such as age-related macular degeneration, may disrupt the crosstalk mechanism we describe here leading to alterations in the homeostasis of choroidal ECM, Bruch's membrane and visual function.

Indexed as

Pregnancy-Associated alpha 2-MacroglobulinsRetinal Pigment EpitheliumAntibodies, BlockingCulture Media, ConditionedEndothelial CellsFemaleGelatinasesHumansMatrix Metalloproteinase 2PregnancyProtease InhibitorsRecombinant ProteinsTranscription FactorsVascular Endothelial Growth Factor AAntibodies, BlockingCulture Media, ConditionedGelatinasesMatrix Metalloproteinase 2Pregnancy-Associated alpha 2-MacroglobulinsProtease InhibitorsRecombinant ProteinsTranscription FactorsVascular Endothelial Growth Factor Aage-related macular degeneration (AMD)Alpha-2-macroglobulin (A2M)Bruch’s membraneendothelial cells (ECs)extracellular matrix (ECM)matrix metalloproteinase-2 (MMP-2)protease inhibitorretinal pigment epithelium (RPE)vascular endothelial growth factor-A (VEGF-A)

Identifiers

PMID36230937
PMCPMC9564307
OpenAlexW4297152875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.